8-K: American Healthcare REIT Closes $388.8M Stock Offering

American Healthcare REIT, Inc. successfully closed a public offering of 8.1 million common shares, valued at $388.8 million, with proceeds intended for general corporate purposes and future investments.

Summary

• American Healthcare REIT, Inc. (AHR) closed a public offering of 8,100,000 shares of its common stock on November 24, 2025.
• The shares were offered at a public offering price of $48.00 per share, totaling approximately $388.8 million.
• The offering included an option for underwriters to purchase up to an additional 1,215,000 shares of common stock for 30 days.
• The company entered into an underwriting agreement with RBC Capital Markets, LLC as the underwriter and forward seller, and an affiliate as the forward purchaser.
• The transaction was structured as a forward sale agreement, where the forward seller borrowed and sold the shares to hedge the forward purchaser's obligations.
• AHR intends to deliver 8,100,000 shares to the forward purchaser upon physical settlement, occurring no later than May 20, 2027, in exchange for cash proceeds per share equal to the public offering price less underwriting discounts and commissions.
• The net proceeds from the settlement of the forward sale agreement will be contributed to the Operating Partnership for general corporate purposes, including potential future investments.

Sentiment

Score: 7

Explanation: The successful closing of a significant capital raise is generally positive for a company's growth prospects, providing funds for strategic initiatives. However, the inherent dilution for existing shareholders and the costs associated with the offering temper the overall sentiment to moderately positive.

Positives

• Successful closing of a significant public offering, raising substantial capital for the company.
• The capital raised is intended for general corporate purposes and potential future investments, supporting strategic growth initiatives.

Negatives

• The issuance of new common stock will result in dilution for existing shareholders.
• Underwriting discounts and commissions reduce the net proceeds received by the company per share.

Risks

• Market disruption events (e.g., trading disruption, exchange disruption, early closure, regulatory disruption) could materially affect the transaction.
• A 'Stock Borrow Event' (inability to borrow shares for hedging or high borrowing costs exceeding 200 basis points per annum) could trigger an acceleration event for the forward sale agreement.
• An 'Ownership Event' where the dealer's share amount exceeds a predefined 'Post-Effective Limit' could also trigger an acceleration event.
• Changes in law or SEC policy could necessitate 'Private Placement Procedures' for share delivery, potentially leading to a discount due to lack of liquidity for restricted shares.
• Counterparty (AHR) agrees not to repurchase shares if the 'Outstanding Share Percentage' (total shares in forward transactions / shares outstanding) would be equal to or greater than 4.5%.
• The company retains the right to elect cash or net share settlement instead of physical settlement under certain conditions, which could alter the financial outcome for the company and the forward purchaser.

Future Outlook

The company intends to use the net proceeds from the forward sale agreement for general corporate purposes, including potential future investments, signaling a focus on growth and strategic expansion.

Industry Context

For a Real Estate Investment Trust (REIT) like American Healthcare REIT, capital raises are a common and essential mechanism to fund property acquisitions, development projects, and other strategic investments, supporting portfolio growth and maintaining competitive positioning within the healthcare real estate sector.

Corporate Governance

Related Party Transactions

• RBC Capital Markets, LLC acted as the underwriter and forward seller, and Royal Bank of Canada, an affiliate of RBC Capital Markets, LLC, acted as the forward purchaser in the transaction.

Stakeholder Impact

• Shareholders: Experience dilution from the issuance of new shares but may benefit from future growth funded by the capital raise.
• Company: Gains significant capital to pursue strategic objectives and strengthen its financial position.

Next Steps

• Physical settlement of the forward sale agreement on one or more dates specified by the company, occurring no later than May 20, 2027.
• Contribution of net proceeds to the Operating Partnership.
• Deployment of net proceeds for general corporate purposes, including potential future investments.

Key Dates

Recommendation

The successful capital raise provides American Healthcare REIT with funds for growth and future investments, which is a positive long-term indicator. However, the immediate impact of share dilution and the standard nature of such an offering for a REIT suggest a 'hold' recommendation, as the filing itself does not present information that would drastically alter the company's fundamental valuation or warrant a strong buy or sell action without further analysis of its investment strategy and market conditions.

Keywords

American Healthcare REIT, AHR, Common Stock Offering, Public Offering, Capital Raise, Forward Sale Agreement, REIT, Healthcare Real Estate, Equity Offering, Underwriting Agreement, SEC Filing, Form 8-K